These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 25801094
1. Kawasaki disease refractory to standard treatments that responds to a combination of pulsed methylprednisolone and plasma exchange: Cytokine profiling and literature review. Matsui M, Okuma Y, Yamanaka J, Uryu H, Sato N, Shichino H, Matsushita T. Cytokine; 2015 Aug; 74(2):339-42. PubMed ID: 25801094 [Abstract] [Full Text] [Related]
2. Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange. Fujimaru T, Ito S, Masuda H, Oana S, Kamei K, Ishiguro A, Kato H, Abe J. Cytokine; 2014 Dec; 70(2):156-60. PubMed ID: 25082649 [Abstract] [Full Text] [Related]
3. Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin. Miura M, Kohno K, Ohki H, Yoshiba S, Sugaya A, Satoh M. Eur J Pediatr; 2008 Oct; 167(10):1119-23. PubMed ID: 18175148 [Abstract] [Full Text] [Related]
4. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial. Ogata S, Ogihara Y, Honda T, Kon S, Akiyama K, Ishii M. Pediatrics; 2012 Jan; 129(1):e17-23. PubMed ID: 22144699 [Abstract] [Full Text] [Related]
5. [Plasma exchange therapy for Kawasaki disease refractory to intravenous immunoglobulin]. Mori M. Nihon Rinsho; 2008 Feb; 66(2):349-54. PubMed ID: 18260334 [Abstract] [Full Text] [Related]
6. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease. Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y. Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370 [Abstract] [Full Text] [Related]
7. Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease. Hokosaki T, Mori M, Nishizawa T, Nakamura T, Imagawa T, Iwamoto M, Yokota S. Pediatr Int; 2012 Feb; 54(1):99-103. PubMed ID: 22004042 [Abstract] [Full Text] [Related]
8. Acute pericardial effusion representing the TNF-α-mediated severe inflammation but not the coronary artery outcome of Kawasaki disease. Okada S, Hasegawa S, Suzuki Y, Matsubara T, Shimomura M, Okuda M, Ichiyama T, Ohga S. Scand J Rheumatol; 2015 May; 44(3):247-52. PubMed ID: 25351965 [Abstract] [Full Text] [Related]
14. Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease. Masuzawa Y, Mori M, Hara T, Inaba A, Oba MS, Yokota S. Ther Apher Dial; 2015 Apr; 19(2):171-7. PubMed ID: 25257673 [Abstract] [Full Text] [Related]
17. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease]. Peng Q, Wu Q, Chen CH, Hong H, Zhang LY. Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593 [Abstract] [Full Text] [Related]
20. [Soluble adhesive molecules and cytokines in patients with myasthenia gravis treated with plasmapheresis]. Tesar V, Jelínková E, Jirsa M, Bakosová N, Pit'ha V, Chábová V. Cas Lek Cesk; 1998 Nov 02; 137(21):654-9. PubMed ID: 9929930 [Abstract] [Full Text] [Related] Page: [Next] [New Search]